TY - JOUR
T1 - ehealth technology in cardiac exercise therapeutics for pediatric patients with congenital and acquired heart conditions
T2 - a summary of evidence and future directions
AU - The Technology Evaluation and Usage in Cardiac and Fitness Rehabilitation (TECH) working group from the Global Coalition for Fitness and Congenital Heart Disease (GLOCO)
AU - White, David A.
AU - Layton, Aimee M.
AU - Curran, Tracy
AU - Gauthier, Naomi
AU - Orr, William B.
AU - Ward, Kendra
AU - Vernon, Meg
AU - Martinez, Matthew N.
AU - Rice, Malloree C.
AU - Hansen, Katherine
AU - Prusi, Megan
AU - Hansen, Jesse E.
N1 - Publisher Copyright:
2023 White, Layton, Curran, Gauthier, Orr, Ward, Vernon, Martinez, Rice, Hansen, Prusi and Hansen.
PY - 2023
Y1 - 2023
N2 - Many children and adolescents with congenital and acquired heart disease (CHD) are physically inactive and participate in an insufficient amount of moderate-to-vigorous intensity exercise. Although physical activity (PA) and exercise interventions are effective at improving short- and long-term physiological and psychosocial outcomes in youth with CHD, several barriers including resource limitations, financial costs, and knowledge inhibit widespread implementation and dissemination of these beneficial programs. New and developing eHealth, mHealth, and remote monitoring technologies offer a potentially transformative and cost-effective solution to increase access to PA and exercise programs for youth with CHD, yet little has been written on this topic. In this review, a cardiac exercise therapeutics (CET) model is presented as a systematic approach to PA and exercise, with assessment and testing guiding three sequential PA and exercise intervention approaches of progressive intensity and resource requirements: (1) PA and exercise promotion within a clinical setting; (2) unsupervised exercise prescription; and (3) medically supervised fitness training intervention (i.e., cardiac rehabilitation). Using the CET model, the goal of this review is to summarize the current evidence describing the application of novel technologies within CET in populations of children and adolescents with CHD and introduce potential future applications of these technologies with an emphasis on improving equity and access to patients in low-resource settings and underserved communities.
AB - Many children and adolescents with congenital and acquired heart disease (CHD) are physically inactive and participate in an insufficient amount of moderate-to-vigorous intensity exercise. Although physical activity (PA) and exercise interventions are effective at improving short- and long-term physiological and psychosocial outcomes in youth with CHD, several barriers including resource limitations, financial costs, and knowledge inhibit widespread implementation and dissemination of these beneficial programs. New and developing eHealth, mHealth, and remote monitoring technologies offer a potentially transformative and cost-effective solution to increase access to PA and exercise programs for youth with CHD, yet little has been written on this topic. In this review, a cardiac exercise therapeutics (CET) model is presented as a systematic approach to PA and exercise, with assessment and testing guiding three sequential PA and exercise intervention approaches of progressive intensity and resource requirements: (1) PA and exercise promotion within a clinical setting; (2) unsupervised exercise prescription; and (3) medically supervised fitness training intervention (i.e., cardiac rehabilitation). Using the CET model, the goal of this review is to summarize the current evidence describing the application of novel technologies within CET in populations of children and adolescents with CHD and introduce potential future applications of these technologies with an emphasis on improving equity and access to patients in low-resource settings and underserved communities.
KW - cardiac rehabilitation
KW - exercise prescription
KW - pediatric cardiology
KW - technology
KW - telehealth
KW - wearable devices
UR - http://www.scopus.com/inward/record.url?scp=85162133718&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85162133718&partnerID=8YFLogxK
U2 - 10.3389/fcvm.2023.1155861
DO - 10.3389/fcvm.2023.1155861
M3 - Review article
C2 - 37332590
AN - SCOPUS:85162133718
SN - 2297-055X
VL - 10
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 1155861
ER -